Market Research Logo

Acute Pain - Pipeline Review, H2 2015

Acute Pain - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H2 2015’, provides an overview of the Acute Pain’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Acute Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Pain and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Acute Pain
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Acute Pain and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Acute Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Acute Pain pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Acute Pain
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Acute Pain pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Acute Pain Overview
Therapeutics Development
Pipeline Products for Acute Pain - Overview
Pipeline Products for Acute Pain - Comparative Analysis
Acute Pain - Therapeutics under Development by Companies
Acute Pain - Therapeutics under Investigation by Universities/Institutes
Acute Pain - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Acute Pain - Products under Development by Companies
Acute Pain - Products under Investigation by Universities/Institutes
Acute Pain - Companies Involved in Therapeutics Development
A. Menarini Industrie Farmaceutiche Riunite Srl
AcelRx Pharmaceuticals, Inc.
Adynxx, Inc.
Amorsa Therapeutics Inc.
AnaBios Corporation
Anavex Life Sciences Corp.
AngioChem Inc.
Antibe Therapeutics, Inc.
AskAt Inc.
Cara Therapeutics, Inc.
Centrexion Corporation
Charleston Laboratories, Inc.
ChironWells GmbH
Cytogel Pharma, LLC
Dompe Farmaceutici S.p.A.
Grunenthal GmbH
INSYS Therapeutics, Inc.
Iroko Pharmaceuticals, LLC
KemPharm, Inc.
Kineta, Inc.
Laboratorios Del Dr. Esteve S.A.
Mallinckrodt Plc
MEDRx Co., Ltd.
Nanomerics Ltd
Nektar Therapeutics
Nuvo Research Inc.
Orbis Biosciences, Inc.
Orexo AB
Orion Oyj
Pacira Pharmaceuticals, Inc.
Phosphagenics Limited
Recro Pharma, Inc.
Shulov Innovative Science Ltd.
Sigma-Tau S.p.A.
Syntrix Biosystems, Inc.
Thar Pharmaceuticals, Inc.
Tonix Pharmaceuticals Holding Corp.
Trevena, Inc.
Yungjin Pharm. Co., Ltd.
Acute Pain - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(acetaminophen + tramadol hydrochloride) - Drug Profile
(acetaminophen + tramadol hydrochloride) SR - Drug Profile
(benzhydrocodone hydrochloride + acetaminophen) IR - Drug Profile
(celecoxib + tramadol hydrochloride) - Drug Profile
(dexketoprofen + tramadol hydrochloride) - Drug Profile
(etodolac + lidocaine) - Drug Profile
(hydrocodone bitartarate + acetaminophen) ER - Drug Profile
(lidocaine + tetracaine) - Drug Profile
AAT-076 - Drug Profile
alfentanil hydrochloride - Drug Profile
AMS-410 FA - Drug Profile
ANAVEX-1037 - Drug Profile
ANAVEX-1066 - Drug Profile
ANAVEX-1067 - Drug Profile
ANAVEX-1079 - Drug Profile
ANAVEX-1519 - Drug Profile
ANG-2002 - Drug Profile
ARX-04 - Drug Profile
ATB-352 - Drug Profile
AYX-1 - Drug Profile
BBI-11008 - Drug Profile
buprenorphine hydrochloride - Drug Profile
celecoxib - Drug Profile
CL-108 - Drug Profile
CLH-10 - Drug Profile
CLH-5 - Drug Profile
CMX-020 - Drug Profile
CR-845 - Drug Profile
Cyt-1010 - Drug Profile
dexmedetomidine hydrochloride - Drug Profile
DF-2593A - Drug Profile
diclofenac sodium - Drug Profile
E-52862 - Drug Profile
ECP-1014 - Drug Profile
ET-1 - Drug Profile
FY-101C - Drug Profile
FY-103B - Drug Profile
grapiprant - Drug Profile
HS-731 - Drug Profile
ibuprofen - Drug Profile
ibuprofen - Drug Profile
ibuprofen - Drug Profile
ketamine hydrochloride - Drug Profile
lidocaine hydrochloride - Drug Profile
lidocaine hydrochloride - Drug Profile
meloxicam - Drug Profile
meloxicam ER - Drug Profile
Monoclonal Antibody to Inhibit TGF-Beta-1 for Acute Pain and Chronic Pancreatitis Pain - Drug Profile
NKTR-192 - Drug Profile
NKTR-195 - Drug Profile
NKTR-196 - Drug Profile
NM-0127 - Drug Profile
oliceridine - Drug Profile
Omnitram - Drug Profile
Peptides to Target TRPV1 for Pain and Itch - Drug Profile
prednisone - Drug Profile
Prostatic Acid Phosphatase - Drug Profile
RO-656570 - Drug Profile
Small Molecule to Block Nav1.9 Channel for Pain - Drug Profile
Small Molecules to Block Nav 1.7 for Pain - Drug Profile
Small Molecules to Block Nav 1.8 for Pain - Drug Profile
ST-4070 - Drug Profile
T-109 - Drug Profile
tapentadol hydrochloride - Drug Profile
TNX-201 - Drug Profile
TRV-734 - Drug Profile
U-2902 - Drug Profile
VPX-595 - Drug Profile
ZEP-3 - Drug Profile
Acute Pain - Recent Pipeline Updates
Acute Pain - Dormant Projects
Acute Pain - Discontinued Products
Acute Pain - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Acute Pain, H2 2015
Number of Products under Development for Acute Pain - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd..1)
Number of Products under Development by Companies, H2 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Development by Companies, H2 2015 (Contd..3)
Products under Development by Companies, H2 2015 (Contd..4)
Products under Investigation by Universities/Institutes, H2 2015
Acute Pain - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2 2015
Acute Pain - Pipeline by AcelRx Pharmaceuticals, Inc., H2 2015
Acute Pain - Pipeline by Adynxx, Inc., H2 2015
Acute Pain - Pipeline by Amorsa Therapeutics Inc., H2 2015
Acute Pain - Pipeline by AnaBios Corporation, H2 2015
Acute Pain - Pipeline by Anavex Life Sciences Corp., H2 2015
Acute Pain - Pipeline by AngioChem Inc., H2 2015
Acute Pain - Pipeline by Antibe Therapeutics, Inc., H2 2015
Acute Pain - Pipeline by AskAt Inc., H2 2015
Acute Pain - Pipeline by Cara Therapeutics, Inc., H2 2015
Acute Pain - Pipeline by Centrexion Corporation, H2 2015
Acute Pain - Pipeline by Charleston Laboratories, Inc., H2 2015
Acute Pain - Pipeline by ChironWells GmbH, H2 2015
Acute Pain - Pipeline by Cytogel Pharma, LLC, H2 2015
Acute Pain - Pipeline by Dompe Farmaceutici S.p.A., H2 2015
Acute Pain - Pipeline by Grunenthal GmbH, H2 2015
Acute Pain - Pipeline by INSYS Therapeutics, Inc., H2 2015
Acute Pain - Pipeline by Iroko Pharmaceuticals, LLC, H2 2015
Acute Pain - Pipeline by KemPharm, Inc., H2 2015
Acute Pain - Pipeline by Kineta, Inc., H2 2015
Acute Pain - Pipeline by Laboratorios Del Dr. Esteve S.A., H2 2015
Acute Pain - Pipeline by Mallinckrodt Plc, H2 2015
Acute Pain - Pipeline by MEDRx Co., Ltd., H2 2015
Acute Pain - Pipeline by Nanomerics Ltd, H2 2015
Acute Pain - Pipeline by Nektar Therapeutics, H2 2015
Acute Pain - Pipeline by Nuvo Research Inc., H2 2015
Acute Pain - Pipeline by Orbis Biosciences, Inc., H2 2015
Acute Pain - Pipeline by Orexo AB, H2 2015
Acute Pain - Pipeline by Orion Oyj, H2 2015
Acute Pain - Pipeline by Pacira Pharmaceuticals, Inc., H2 2015
Acute Pain - Pipeline by Phosphagenics Limited, H2 2015
Acute Pain - Pipeline by Recro Pharma, Inc., H2 2015
Acute Pain - Pipeline by Shulov Innovative Science Ltd., H2 2015
Acute Pain - Pipeline by Sigma-Tau S.p.A., H2 2015
Acute Pain - Pipeline by Syntrix Biosystems, Inc., H2 2015
Acute Pain - Pipeline by Thar Pharmaceuticals, Inc., H2 2015
Acute Pain - Pipeline by Tonix Pharmaceuticals Holding Corp., H2 2015
Acute Pain - Pipeline by Trevena, Inc., H2 2015
Acute Pain - Pipeline by Yungjin Pharm. Co., Ltd., H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Acute Pain Therapeutics - Recent Pipeline Updates, H2 2015
Acute Pain - Dormant Projects, H2 2015
Acute Pain - Dormant Projects (Contd..1), H2 2015
Acute Pain - Dormant Projects (Contd..2), H2 2015
Acute Pain - Dormant Projects (Contd..3), H2 2015
Acute Pain - Dormant Projects (Contd..4), H2 2015
Acute Pain - Dormant Projects (Contd..5), H2 2015
Acute Pain - Discontinued Products, H2 2015
Acute Pain - Discontinued Products (Contd..1), H2 2015
List of Figures
Number of Products under Development for Acute Pain, H2 2015
Number of Products under Development for Acute Pain - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report